Saint Luke’s Clinical Trial Shows Improvements in Patients with Common Genetic Heart Condition

Saint Luke’s Clinical Trial Shows Improvements in Patients with Common Genetic Heart Condition Saint Luke’s Mid America Heart Institute announced the results of a clinical trial that will impact patient care and improve quality of life for patients suffering from the most common genetic heart condition, called hypertrophic cardiomyopathy (HCM).